Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Critical Reviews in Oncogenesis is Scopus-indexed (Q4, CiteScore 2.7). Published by Begell House Inc..
Checked against the index lists dated .
ISSN 0893-9675Verify ISSN ↗2162-6448Verify ISSN ↗
Publisher: Begell House Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cancer Research | 181 / 233 | 22nd | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present (also 2006–2009, 1989–2000), best quartile Q4, CiteScore 2.7.
Critical Reviews in Oncogenesis is Q4 in Cancer Research (rank 181 of 233), by CiteScore 2025.
Critical Reviews in Oncogenesis is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.7, quartile Q4, 22nd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.565, quartile Q2, with an H-index of 60.
Critical Reviews in Oncogenesis is published by Begell House Inc. Its print ISSN is 0893-9675 and its online ISSN is 2162-6448.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Critical Reviews in Oncogenesis has an h-index of 66 and a 2-year mean of 1.19 citations per paper (OpenAlex). Its Scopus CiteScore is 2.7, quartile Q4. On 2-year citations it ranks #178 of 229 Scopus journals in Cancer Research.
Critical Reviews in Oncogenesis published 42 papers in 2025; its busiest recent year was 2023 with 58. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 74 research articles (2023–2026), authors are most often from United States (45.9%), India (23%) and Israel (9.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.